Global Retirement Partners, LLC Sage Therapeutics, Inc. Transaction History

Global Retirement Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$17.1 - $22.26 $68 - $89	-4 Reduced 17.39%	19 $0
Q3 2023 Oct 13, 2023	BUY	$16.75 - $48.98 $83 - $244	5 Added 27.78%	23 $0
Q2 2023 Jul 20, 2023	SELL	$40.65 - $59.54 $40 - $59	-1 Reduced 5.26%	18 $0
Q1 2023 May 05, 2023	BUY	$37.27 - $46.57 $708 - $884	19 New	19 $0
Q4 2019 Jan 23, 2020	SELL	$60.18 - $154.77 $240 - $619	-4 Closed	0 $0
Q2 2019 Nov 19, 2019	BUY	$157.85 - $183.09 $631 - $732	4 New	4 $1,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Global Retirement Partners, LLC with notifications on news.